Page last updated: 2024-11-07

r 84760

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

R 84760: kappa opioid receptor agonist; R-84760 is the (1R,2S)-isomer; R-86428 is the (1S,2R)-isomer; R-84761 is the (1R,2R)-isomer; R-86436 is the (1S,2S)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133035
MeSH IDM0240662

Synonyms (22)

Synonym
gw7gy73veg ,
unii-gw7gy73veg
157824-23-2
r 84760
r 86436
r 84761
r-84760
3-(1-pyrrolidinylmethyl)-4-(5,6-dichloro-1-indancarbonyl)-tetrahydro-1,4-thiazine hydrochloride
r 86428
r-86428
thiomorpholine, 4-((5,6-dichloro-2,3-dihydro-1h-inden-1-yl)carbonyl)-3-(1-pyrrolidinylmethyl)-, monohydrochloride, (r-(r*,s*))-
r-84761
r-86436
157824-23-2 (hcl)
((s)-5,6-dichloro-2,3-dihydro-1h-inden-1-yl)((r)-3-(pyrrolidin-1-ylmethyl)thiomorpholino)methanone hydrochloride
r-84760 hydrochloride
DTXSID60935809
(5,6-dichloro-2,3-dihydro-1h-inden-1-yl){3-[(pyrrolidin-1-yl)methyl]thiomorpholin-4-yl}methanone--hydrogen chloride (1/1)
[(1s)-5,6-dichloro-2,3-dihydro-1h-inden-1-yl]-[(3r)-3-(pyrrolidin-1-ylmethyl)thiomorpholin-4-yl]methanone;hydrochloride
r84760
methanone, ((1s)-5,6-dichloro-2,3-dihydro-1h-inden-1-yl)((3r)-3-(1-pyrrolidinylmethyl)-4-thiomorpholinyl)-, hydrochloride (1:1)
AKOS040749268

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The plasma concentration of unchanged form after administration at a trace dosage amount was able to be monitored."( Quantitative analysis of R-84760, a selective kappa-opioid receptor agonist, in plasma by liquid chromatography with electrospray ionization tandem mass spectrometry.
Kobayashi, N; Naganuma, H, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]